SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-16-000920
Filing Date
2016-07-22
Accepted
2016-07-21 17:42:08
Documents
49
Period of Report
2016-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt013116form10q.htm 10-Q 565934
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 18048
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 16365
4 EXHIBIT 32 ex32.htm EX-32 4666
  Complete submission text file 0001607062-16-000920.txt   2308414

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20160131.xml EX-101.INS 284324
6 XBRL SCHEMA FILE gnbt-20160131.xsd EX-101.SCH 31984
7 XBRL CALCULATION FILE gnbt-20160131_cal.xml EX-101.CAL 27420
8 XBRL DEFINITION FILE gnbt-20160131_def.xml EX-101.DEF 107432
9 XBRL LABEL FILE gnbt-20160131_lab.xml EX-101.LAB 181559
10 XBRL PRESENTATION FILE gnbt-20160131_pre.xml EX-101.PRE 157634
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 161778079
SIC: 2834 Pharmaceutical Preparations